Mostrar el registro sencillo del ítem
dc.contributor.author | Beltrame, Anna | es_ES |
dc.contributor.author | Salguero-García, Pedro | es_ES |
dc.contributor.author | Rossi, Emanuela | es_ES |
dc.contributor.author | Conesa, Ana | es_ES |
dc.contributor.author | Moro, Lucia | es_ES |
dc.contributor.author | Bettini, Laura Rachele | es_ES |
dc.contributor.author | Rizzi, Eleonora | es_ES |
dc.contributor.author | D Angió, Mariella | es_ES |
dc.contributor.author | Deiana, Michela | es_ES |
dc.contributor.author | Piubelli, Chiara | es_ES |
dc.contributor.author | Rebora, Paola | es_ES |
dc.contributor.author | Duranti, Silvia | es_ES |
dc.contributor.author | Bonfanti, Paolo | es_ES |
dc.contributor.author | Capua, Ilaria | es_ES |
dc.contributor.author | Tarazona, Sonia | es_ES |
dc.date.accessioned | 2023-03-23T19:01:35Z | |
dc.date.available | 2023-03-23T19:01:35Z | |
dc.date.issued | 2022-01-27 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10251/192566 | |
dc.description.abstract | [EN] Understanding the cause of sex disparities in COVID-19 outcomes is a major challenge. We investigate sex hormone levels and their association with outcomes in COVID-19 patients, stratified by sex and age. This observational, retrospective, cohort study included 138 patients aged 18 years or older with COVID-19, hospitalized in Italy between February 1 and May 30, 2020. The association between sex hormones (testosterone, estradiol, progesterone, dehydroepiandrosterone) and outcomes (ARDS, severe COVID-19, in-hospital mortality) was explored in 120 patients aged 50 years and over. STROBE checklist was followed. The median age was 73.5 years [IQR 61, 82]; 55.8% were male. In older males, testosterone was lower if ARDS and severe COVID-19 were reported than if not (3.6 vs. 5.3 nmol/L, p =0.0378 and 3.7 vs. 8.5 nmol/L, p =0.0011, respectively). Deceased males had lower testosterone (2.4 vs. 4.8 nmol/L, p =0.0536) and higher estradiol than survivors (40 vs. 24 pg/mL, p = 0.0006). Testosterone was negatively associated with ARDS (OR 0.849 [95% CI 0.734, 0.982]), severe COVID-19 (OR 0.691 [95% CI 0.546, 0.874]), and in-hospital mortality (OR 0.742 [95% CI 0.566, 0.972]), regardless of potential confounders, though confirmed only in the regression model on males. Higher estradiol was associated with a higher probability of death (OR 1.051 [95% CI 1.018, 1.084]), confirmed in both sex models. In males, higher testosterone seems to be protective against any considered outcome. Higher estradiol was associated with a higher probability of death in both sexes. | es_ES |
dc.description.sponsorship | The research was funded by Italian Ministry of Health Fondi Ricerca Corrente, Project L1P5 for IRCCS Sacro Cuore Don Calabria Hospital. The funding source had no role in the collection, analysis, or interpretation of data, the study design, or the writing of the paper. | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | Frontiers Media | es_ES |
dc.relation.ispartof | Frontiers in Immunology | es_ES |
dc.rights | Reconocimiento (by) | es_ES |
dc.subject | Sex hormones | es_ES |
dc.subject | COVID-19 | es_ES |
dc.subject | Outcome | es_ES |
dc.subject | ARDS | es_ES |
dc.subject | Severity | es_ES |
dc.subject | Testosterone | es_ES |
dc.subject | Estradiol | es_ES |
dc.subject.classification | ESTADISTICA E INVESTIGACION OPERATIVA | es_ES |
dc.title | Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.3389/fimmu.2022.834851 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/Ministero della Salute//L1P5//Fondi Ricerca Corrente/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Escola Tècnica Superior d'Enginyeria Informàtica | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Departamento de Estadística e Investigación Operativa Aplicadas y Calidad - Departament d'Estadística i Investigació Operativa Aplicades i Qualitat | es_ES |
dc.description.bibliographicCitation | Beltrame, A.; Salguero-García, P.; Rossi, E.; Conesa, A.; Moro, L.; Bettini, LR.; Rizzi, E.... (2022). Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study. Frontiers in Immunology. 13:1-10. https://doi.org/10.3389/fimmu.2022.834851 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | https://doi.org/10.3389/fimmu.2022.834851 | es_ES |
dc.description.upvformatpinicio | 1 | es_ES |
dc.description.upvformatpfin | 10 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 13 | es_ES |
dc.identifier.eissn | 1664-3224 | es_ES |
dc.identifier.pmid | 35154158 | es_ES |
dc.identifier.pmcid | PMC8829540 | es_ES |
dc.relation.pasarela | S\454194 | es_ES |
dc.contributor.funder | Ministero della Salute | es_ES |